175 related articles for article (PubMed ID: 24931646)
1. The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.
Yoshida K; Yoshida S; Choisunirachon N; Saito T; Matsumoto K; Saeki K; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
J Vet Med Sci; 2014 Oct; 76(10):1321-7. PubMed ID: 24931646
[TBL] [Abstract][Full Text] [Related]
2. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
3. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors.
Tateyama S; Uchida K; Hidaka T; Hirao M; Yamaguchi R
Vet Pathol; 2001 Nov; 38(6):703-9. PubMed ID: 11732805
[TBL] [Abstract][Full Text] [Related]
4. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
5. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
Sakai K; Yonezawa T; Yamawaki H; Oyamada T
J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
[TBL] [Abstract][Full Text] [Related]
6. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.
Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K
Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797
[TBL] [Abstract][Full Text] [Related]
8. Relationship between receptors for insulin-like growth factor- I, steroid hormones and apoptosis-associated proteins in canine mammary tumors.
Dolka I; Motyl T; Malicka R; Sapierzyński E; Fabisiak M
Pol J Vet Sci; 2011; 14(2):245-51. PubMed ID: 21721409
[TBL] [Abstract][Full Text] [Related]
9. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
10. Expression of Tumour Endothelial Marker 8 in Canine Mammary Gland Tumour Cells.
Noguchi S; Araki M; Nakajima K; Koh M; Kokado Y; Kubo Y; Otsuka H; Yasuda A; Yokosuka M; Soeta S
J Comp Pathol; 2019 Nov; 173():30-40. PubMed ID: 31812171
[TBL] [Abstract][Full Text] [Related]
11. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
12. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
13. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin immunoreactivity in canine mammary tumors.
Sarli G; Preziosi R; De Tolla L; Brunetti B; Benazzi C
J Vet Diagn Invest; 2004 Nov; 16(6):542-7. PubMed ID: 15586569
[TBL] [Abstract][Full Text] [Related]
15. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
Lee HJ; Han HJ; Lee JY; Son WC
Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
Reis AL; Carvalheira J; Schmitt FC; Gärtner F
Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of SLUG expression in canine mammary gland tumors and its prognostic significance.
Cheon SB; Kim WH
BMC Vet Res; 2023 Aug; 19(1):112. PubMed ID: 37553661
[TBL] [Abstract][Full Text] [Related]
18. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
[TBL] [Abstract][Full Text] [Related]
20. ZEB and Snail expression indicates epithelial-mesenchymal transition in canine melanoma.
Veloso ES; Gonçalves INN; Silveira TL; Espirito Santo JT; Figueiredo LV; Varaschin MS; Cassali GD; Del Puerto HL; Ferreira E
Res Vet Sci; 2020 Aug; 131():7-14. PubMed ID: 32278962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
